1:00:57

Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar

20:59

The Blessing and Curse of Direct Oral Anticoagulants in the Bleeding Patient

11:35

Anticoagulation Reversal Strategies

25:12

Deborah Siegal, MD, MSc, FRCPC presents Updates in Anticoagulation Reversal

37:41

DOACs in Renal Dysfunction and Liver Disease

3:10:39

Antiplatelet, Anticoagulant, Thrombolytic Agents

17:18

Boost Your Bone Density with These 6 Life-Changing Tips

32:51

Reversing oral anticoagulants with a focus on Andexanet Alfa